The leading stock exchanges in Europe tended at lunchtime on Wednesday with narrow spreads. The Euro-Stoxx-50 stood at around 12:15 p.m. with an increase of 0.14 percent at 3,584.41 points. The Frankfurt DAX gained a slight 0.11 percent to 13,776.17 units. In London, the FTSE-100 rose 0.2 percent to 6,615.74 points.
On many stock exchanges, Wednesday is the last trading day of a turbulent stock market year. In Frankfurt there is already only shortened trading today – the DAX will close at 2 p.m. today. In the meantime, trading in Paris and London will also take place on New Year’s Eve tomorrow, albeit shortened.
Trade should continue to be calm for the rest of the day. Economic data that could cause movement are not expected. Consumer price data from Spain received little attention. In addition, according to market experts, many investors have already closed their books for this year.
The year 2020 was also dominated by the Covid 19 pandemic on the European markets. Some indices have already been able to make up for the corona-induced price slump, driven by economic stimulus and vaccine euphoria. The DAX, for example, is heading for an annual plus of around 4 percent. The Euro-Stoxx-50, however, should end the year with around 4 percent in the red.
According to analysts, however, the markets are also taking a heavy toll on the recent gains. It remains to be seen whether the hoped-for recovery from the Covid crisis, which has already been anticipated on the stock exchanges, remains to be seen, according to market experts.
In the leading euro zone index, bank stocks showed their good side at noon on Wednesday. The shares of Banco Santander rose above average by 0.5 percent. Meanwhile, the shares of the brewery group AB InBev went down by a significant 1.7 percent.
The shares of the British pharmaceutical company AstraZeneca gained 0.5 percent on the London Stock Exchange. Great Britain was the first country in the world to approve the corona vaccine that AstraZeneca developed in collaboration with Oxford University. This means that after the Biontech / Pfizer vaccine, another preparation is available in the country for vaccination.
–
